tiprankstipranks
Trending News
More News >
TME Pharma N.V. (DE:0N6A)
FRANKFURT:0N6A
Germany Market

TME Pharma N.V. (0N6A) Financial Statements

Compare
1 Followers

TME Pharma N.V. Financial Overview

TME Pharma N.V.'s market cap is currently €5.78M. The company's EPS TTM is €-0.022; its P/E ratio is -1.19; TME Pharma N.V. is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue€ 19.00K€ 17.00K€ 0.00€ 33.00K€ 35.00
Gross Profit€ -78.00K€ -127.00K€ -92.00K€ -65.97K€ -62.97K
Operating Income€ -5.28M€ -5.62M€ -12.03M€ -13.27M€ -5.77M
EBITDA€ -5.25M€ -5.07M€ -11.63M€ -12.88M€ -5.29M
Net Income€ -5.72M€ -6.74M€ -15.13M€ -14.45M€ -10.40M
Balance Sheet
Cash & Short-Term Investments€ 3.25M€ 2.25M€ 4.63M€ 9.48M€ 10.30M
Total Assets€ 3.41M€ 2.49M€ 5.24M€ 9.77M€ 10.65M
Total Debt€ 56.00K€ 1.17M€ 4.09M€ 2.44M€ 653.00K
Net Debt€ -3.24M€ -1.08M€ -548.00K€ -7.02M€ -10.23M
Total Liabilities€ 1.79M€ 2.79M€ 6.51M€ 5.27M€ 2.96M
Stockholders' Equity€ 1.61M€ -294.00K€ -1.27M€ 4.51M€ 7.71M
Cash Flow
Free Cash Flow€ -4.65M€ -5.65M€ -12.16M€ -12.39M€ -5.26M
Operating Cash Flow€ -4.63M€ -5.63M€ -12.14M€ -12.38M€ -5.22M
Investing Cash Flow€ -21.00K€ -19.00K€ -21.00K€ -14.00K€ -39.00K
Financing Cash Flow€ 5.66M€ 3.27M€ 7.29M€ 11.50M€ 14.18M
Currency in EUR

TME Pharma N.V. Earnings and Revenue History

TME Pharma N.V. Debt to Assets

TME Pharma N.V. Cash Flow

TME Pharma N.V. Forecast EPS vs Actual EPS